all procceeding well, page-17

Couldn't agree more Mattster.

My speculative analysis of things:

1. Results to be reported in October is very interesting timing;
2. Neil leaving at the end of the year December 31;
3. Mat has commented on a number of occasions about seeking partnerships after the 2b results;
4. Expansions into Europe, Asia and America prior to any approvals (on a punt?????);
5. Strong networks. (Malcolm Turnbull. Need we say more);
6. Increasing exposure and volumes in the US.

There are others that I'm sure you all know.

Now, what does this mean??

My belief, they know it works, partnership probably ready and watching post trial results, thus Neil's job is done, and the Big fat cat pharma's take over. Massive market reach (Asia, Europe, US and of course Aus).

Are they learning from DNDN? Absolutely. DNDN trying to get into Europe (massive costs being incurred). We are all over the place, with what I consider petty cash (in comparison).

PRR is by no means dead horse. It's just warming up ready to run the biggest race of its life.

Good luck to all long termers.

GO CVAC!!